Personalized Medicine: A Review with Regard to Biomarkers

Behzad Foroutan(Shahroud University of Medical Sciences)
Journal of Bioequivalence & Bioavailability
January 1, 2015
10.4172/jbb.1000248
Cited by 19Open Access
Full Text

Abstract

Dramatic advances in information technology are driving systems change. The United States (US) and other countries are currently making multibillion-dollar investments to implement Electronic health records

Related Papers

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
Arthur J. Atkinson|Clinical Pharmacology & Therapeutics|2001|6.6k
Exploring the new world of the genome with DNA microarrays
Patrick O. Brown, David Botstein|Nature Genetics|1999|2.4k
Thalidomide‐induced teratogenesis: History and mechanisms
Neil Vargesson|Birth Defects Research Part C Embryo Today Reviews|2015|876
Accumulation of driver and passenger mutations during tumor progression
Ivana Božić, Tibor Antal, Hisashi Ohtsuki et al.|Proceedings of the National Academy of Sciences|2010|850
The emerging complexity of gene fusions in cancer
Fredrik Mertens, Bertil Johansson, Thoas Fioretos et al.|Nature reviews. Cancer|2015|692